146 related articles for article (PubMed ID: 25847223)
41. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
[TBL] [Abstract][Full Text] [Related]
42. Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells.
Wan CK; Andraski AB; Spolski R; Li P; Kazemian M; Oh J; Samsel L; Swanson PA; McGavern DB; Sampaio EP; Freeman AF; Milner JD; Holland SM; Leonard WJ
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9394-9. PubMed ID: 26170288
[TBL] [Abstract][Full Text] [Related]
43. High Dimensional Analyses of Circulating Immune Cells in Psoriatic Arthritis Detects Elevated Phosphorylated STAT3.
Macaubas C; Rahman SS; Lavi I; Haddad A; Elias M; Sengupta D; Zisman D; Mellins ED
Front Immunol; 2021; 12():758418. PubMed ID: 35087513
[TBL] [Abstract][Full Text] [Related]
44. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells.
Oberg HH; Wesch D; Grüssel S; Rose-John S; Kabelitz D
Int Immunol; 2006 Apr; 18(4):555-63. PubMed ID: 16540526
[TBL] [Abstract][Full Text] [Related]
45. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
[TBL] [Abstract][Full Text] [Related]
46. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
47. TNFα promotes Th17 cell differentiation through IL-6 and IL-1β produced by monocytes in rheumatoid arthritis.
Zheng Y; Sun L; Jiang T; Zhang D; He D; Nie H
J Immunol Res; 2014; 2014():385352. PubMed ID: 25436214
[TBL] [Abstract][Full Text] [Related]
48. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.
Nissinen R; Leirisalo-Repo M; Peltomaa R; Palosuo T; Vaarala O
Ann Rheum Dis; 2004 Jun; 63(6):681-7. PubMed ID: 15140775
[TBL] [Abstract][Full Text] [Related]
49. Time course of signaling profiles of blood leukocytes in acute pancreatitis and sepsis.
Turunen A; Kuuliala A; Penttilä A; Kaukonen KM; Mustonen H; Pettilä V; Puolakkainen P; Kylänpää L; Kuuliala K
Scand J Clin Lab Invest; 2020; 80(2):114-123. PubMed ID: 31833422
[TBL] [Abstract][Full Text] [Related]
50. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
51. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
[TBL] [Abstract][Full Text] [Related]
52. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
[TBL] [Abstract][Full Text] [Related]
53. Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.
Wang SP; Iwata S; Nakayamada S; Niiro H; Jabbarzadeh-Tabrizi S; Kondo M; Kubo S; Yoshikawa M; Tanaka Y
Rheumatology (Oxford); 2015 Aug; 54(8):1488-97. PubMed ID: 25724205
[TBL] [Abstract][Full Text] [Related]
54. The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon.
Rosengren S; Corr M; Firestein GS; Boyle DL
Ann Rheum Dis; 2012 Mar; 71(3):440-7. PubMed ID: 22121136
[TBL] [Abstract][Full Text] [Related]
55. STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy.
Wang W; Edington HD; Rao UN; Jukic DM; Wang H; Shipe-Spotloe JM; Kirkwood JM
J Invest Dermatol; 2008 Aug; 128(8):1997-2002. PubMed ID: 18305569
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis.
Syngle A; Verma I; Krishan P
Acta Reumatol Port; 2015; 40(1):85-8. PubMed ID: 24863079
[TBL] [Abstract][Full Text] [Related]
57. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
[TBL] [Abstract][Full Text] [Related]
58. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus.
Valencia-Pacheco G; Layseca-Espinosa E; Niño-Moreno P; Portales-Pérez DP; Baranda L; Rosenstein Y; Abud-Mendoza C; González-Amaro R
Scand J Rheumatol; 2006; 35(5):368-78. PubMed ID: 17062437
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
60. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis.
Morita Y; Yamamura M; Kawashima M; Harada S; Tsuji K; Shibuya K; Maruyama K; Makino H
Arthritis Rheum; 1998 Sep; 41(9):1669-76. PubMed ID: 9751101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
